- Home
- OIS vs XFOR Comparison
OIS vs XFOR Comparison
Compare OIS & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | XFOR |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | 143 |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.3M | 407.5M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | OIS | XFOR |
|---|---|---|
| Price | $12.20 | $4.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $14.00 | ★ $25.20 |
| AVG Volume (30 Days) | ★ 1.0M | 496.8K |
| Earning Date | 04-30-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $5.36 | $80.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $3.08 | $0.17 |
| 52 Week High | $14.50 | $6.63 |
Technical Indicators
Market Signals| Indicator | OIS | XFOR |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 52.84 |
| Support Level | $11.52 | $3.01 |
| Resistance Level | $14.50 | $4.34 |
| Average True Range (ATR) | 0.49 | 0.36 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 53.00 | 40.00 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.